Co-Mepiryl
Combination Therapy for Type 2 Diabetes Management
Co-Mepiryl is an oral antidiabetic medication used to help control blood sugar levels in individuals with Type 2 Diabetes Mellitus. It combines Glimepiride, which stimulates insulin production, and Metformin, which improves insulin sensitivity and reduces glucose production in the liver. This dual-action formula helps regulate blood sugar levels effectively, reducing the risk of diabetes-related complications.
Active Ingredients
- Glimepiride – A sulfonylurea that stimulates the pancreas to release more insulin.
- Metformin – A biguanide that reduces glucose production in the liver and improves insulin sensitivity.
Indications (Uses)
Co-Mepiryl is prescribed for:
- Managing Type 2 Diabetes Mellitus when diet and exercise alone are insufficient.
- Combination therapy for individuals requiring dual treatment to control blood sugar levels.
- Reducing the risk of diabetes-related complications such as heart disease and kidney problems.
Dosage and Administration
- Adults: Take one tablet once or twice daily, as prescribed by a doctor.
- Take with food to reduce the risk of stomach upset.
- Swallow whole with water—do not crush or chew.
- Follow a balanced diet and exercise plan for the best results.
Precautions and Warnings
- Not for use in Type 1 Diabetes or diabetic ketoacidosis.
- Monitor blood sugar levels regularly to avoid hypoglycemia or hyperglycemia.
- May cause low blood sugar (hypoglycemia), especially if meals are skipped.
- Use with caution in patients with kidney, liver, or heart conditions.